Tekla Capital Management LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 154 filers reported holding ACCELERON PHARMA INC in Q1 2018. The put-call ratio across all filers is 3.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q2 2020$3,869,000
+6.0%
40,6060.0%0.15%
-10.9%
Q1 2020$3,649,000
-20.3%
40,606
-53.0%
0.16%
-4.6%
Q4 2019$4,576,000
+34.2%
86,3130.0%0.17%
+16.1%
Q3 2019$3,410,000
-55.9%
86,313
-54.2%
0.15%
-52.8%
Q2 2019$7,739,000
-11.8%
188,3880.0%0.32%
-11.2%
Q1 2019$8,773,000
+18.0%
188,388
+10.3%
0.36%
+11.9%
Q4 2018$7,437,000
-23.9%
170,7660.0%0.32%
-10.2%
Q3 2018$9,773,000
+17.9%
170,7660.0%0.35%
+12.7%
Q2 2018$8,286,000
-22.4%
170,766
-37.5%
0.31%
-24.3%
Q1 2018$10,678,000
-11.2%
273,098
-3.6%
0.42%
-10.6%
Q4 2017$12,027,000
+440.3%
283,383
+375.0%
0.46%
+480.0%
Q3 2017$2,226,000
+22.8%
59,6540.0%0.08%
+19.4%
Q2 2017$1,813,000
+25.8%
59,654
+9.6%
0.07%
+19.6%
Q1 2017$1,441,000
+3.7%
54,4500.0%0.06%
-5.1%
Q4 2016$1,390,00054,4500.06%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 917,767$52,524,0008.19%
Foresite Capital Management II, LLC 220,268$12,606,0004.66%
Foresite Capital Management III, LLC 250,863$14,357,0003.17%
Novo Holdings A/S 650,000$37,200,0002.95%
QVT Financial LP 190,977$10,930,0002.82%
Perceptive Advisors 1,528,205$87,459,0002.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,117,651$63,963,0002.29%
Asymmetry Capital Management, L.P. 39,912$2,284,0002.11%
SECTORAL ASSET MANAGEMENT INC 298,726$17,096,0001.82%
Stanley-Laman Group, Ltd. 125,020$7,155,0001.76%
View complete list of ACCELERON PHARMA INC shareholders